Detection and characterization of Lewis antigens in plasma of Lewis-negative individuals. Evidence of chain extension as a result of reduced fucosyltransferase competition.
Nonacid plasma glycolipids from Lewis-negative individuals of nonsecretor, partial-secretor and secretor phenotypes were prepared and separated by thin-layer chromatography and immunostained with radiolabelled Lewis antibodies. Lewis-positive plasma and intestinal epithelial cell glycolipids from Caucasians representing the four recognized Lewis and secretor combined phenotypes were used as controls. By presenting these purified total glycolipids in a cell-free environment to Lewis antibodies we were able to demonstrate the presence of small amounts of Lewis antigens in Lewis-negative individuals. It is shown that lactotetraosylceramide and extended precursor glycolipids are present in all Le(a-b-) nonsecretors. Le(a) was detected in 1 of the 3 Le(a-b-) nonsecretor plasmas and in the intestinal sample of the same phenotype. Lactotetraosylceramide was absent but H type 1 and Le(b) were both present in all group O Le(a-b-) secretors, and extended H type 1 reactive structures were also found in the partial secretor. These results clearly demonstrate that although the Lewis-negative phenotype exists at the serological level, this phenotype is not an 'all-or-nothing' phenomenon at the chemical level. We also show that in the presence of reduced fucosyltransferase activity, increased elongation of the precursor chain occurs, which allows us to postulate that fucosylation of the precursor prevents or at least markedly reduces chain elongation.
Henry
S M
SM
Department of Transfusion Medicine, Auckland Regional Blood Centre, New Zealand.
Oriol
R
R
Samuelsson
B E
BE
D000017:ABO Blood-Group System / Q000276:immunology; D000328:Adult; D001788:Blood Grouping and Crossmatching / Q000379:methods*; D002240:Carbohydrate Sequence; D005006:Ethnicity / Q000235:genetics; D005647:Fucosyltransferases / Q000235:genetics / Q000378:metabolism; D006017:Glycolipids / Q000378:metabolism*; D006031:Glycosylation; D006801:Humans; D007106:Immune Sera; D007421:Intestine, Small / Q000737:chemistry; D007983:Lewis Blood Group Antigens / Q000276:immunology*; D008954:Models, Biological; D008969:Molecular Sequence Data; D011114:Polynesia; D012463:Saliva / Q000276:immunology; D012471:Salivary Proteins and Peptides / Q000032:analysis*; D044465:White People / Q000235:genetics; D000097631:Galactoside 2-alpha-L-fucosyltransferase
D000017:ABO Blood-Group System; D005647:Fucosyltransferases; D006017:Glycolipids; D007106:Immune Sera; D007983:Lewis Blood Group Antigens; D012471:Salivary Proteins and Peptides; D000097631:Galactoside 2-alpha-L-fucosyltransferase; C031692:galactoside 3-fucosyltransferase; C019818:3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase